Targeting ENaC as a Molecular Suspect in Cystic Fibrosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|16|9|951-957

ISSN： 1389-4501

Source： Current Drug Targets, Vol.16, Iss.9, 2015-01, pp. : 951-957

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ENaC Inhibitors and Airway Re-hydration in Cystic Fibrosis: State of the Art

By  

Current Molecular Pharmacology, Vol. 6, Iss. 1, 2013-03 ,pp. : 3-12

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Molecular Chaperones for the Treatment of Cystic Fibrosis: Is It a Viable Approach?

By  

Current Drug Targets, Vol. 16, Iss. 9, 2015-01 ,pp. : 958-964

Bentham Science Publishers

Access to resources Recommend Favorite

ENaC Modulators and Renal Disease

By  

Current Molecular Pharmacology, Vol. 6, Iss. 1, 2013-03 ,pp. : 35-43

Bentham Science Publishers

Access to resources Recommend Favorite

Kinases as Targets for ENaC Regulation

By  

Current Molecular Pharmacology, Vol. 6, Iss. 1, 2013-03 ,pp. : 50-64

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting neutrophil elastase in cystic fibrosis

By Kelly Emer   Greene Catherine M   McElvaney Noel G  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 2, 2008-02 ,pp. : 145-157

Informa Healthcare

Access to resources Recommend Favorite